Role of lymphadenectomy for ovarian cancer.
10.3802/jgo.2014.25.4.279
- Author:
Mikio MIKAMI
1
Author Information
1. Department of Obstetrics and Gynecology, Tokai University School of Medicine, Isehara, Japan. mmikami@is.icc.u-tokai.ac.jp
- Publication Type:Randomized Controlled Trial ; Editorial
- Keywords:
Lymphadenectomy;
Ovarian cancer
- MeSH:
Cytoreduction Surgical Procedures/methods;
Female;
Humans;
Lymph Node Excision/*methods;
Lymphatic Metastasis;
Neoplasm Staging;
Ovarian Neoplasms/*pathology/therapy;
Practice Guidelines as Topic
- From:Journal of Gynecologic Oncology
2014;25(4):279-281
- CountryRepublic of Korea
- Language:English
-
Abstract:
Japan Society of Gynecologic Oncology (JSGO) recently revised its Ovarian Cancer Treatment Guidelines and the 4th edition will be released next year. This Guidelines state that lymphadenectomy is essential to allow accurate assessment of the clinical stage in early ovarian cancer, but there is no randomized controlled trial that shows any therapeutic efficacy of lymphadenectomy. In patients with advanced stage tumors, lymphadenectomy should be considered if optimal debulking has been performed. I fully agree with this recommendation of the JSGO and I would like to discuss the role of lymphadenectomy in the management of ovarian cancer.
